Lexicon Pharmaceuticals
LXRX
#7435
Rank
A$0.64 B
Marketcap
A$1.77
Share price
-0.85%
Change (1 day)
53.16%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): A-$0.30

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$0.29. In 2024 the company made an earnings per share (EPS) of A-$0.97 an increase over its 2023 EPS that were of A-$1.21.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.30-68.77%
2024A-$0.97-20%
2023A-$1.2131.15%
2022A-$0.92-0%
2021A-$0.9210.91%
2020A-$0.83-145.08%
2019A$1.84-206.09%
2018A-$1.74-5.74%
2017A-$1.84-10.95%
2016A-$2.072640%
2015A-$0.07559-96.34%
2014A-$2.06-2.53%
2013A-$2.12-9.09%
2012A-$2.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
A-$115.98 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$65.68-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$8.98 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$4.11-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$26.22-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.76 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$6.76-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$3.61-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A-$1.13 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA